Triple therapy of an inhaled corticosteroid, long acting β 2-agonist (LABA), and long acting muscarinic antagonist (LAMA) is more effective in reducing the annual rate of exacerbations compared with ...

Novartis and Qualcomm are to develop a 'smart' COPD inhaler to allow patients to digitally monitor their medication. The announcement follows similar plans by Novartis's rivals in the respiratory ...

is to work with Qualcomm to 'digitally upgrade' its Respimat inhaler, introducing a new connectivity solution to improve medication adherence in chronic obstructive pulmonary disorder (COPD ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016 ... 10% prescribed LAMA/LABA/ICS via a single inhaler, 3% prescribed LAMA/LABA/ICS via multiple ...

Introduction Inhaler adherence in Chronic Obstructive Pulmonary Disease (COPD) is a crucial component of disease management with studies reporting relationships with both morbidity and mortality. The ...

These failures among hospitalized COPD patients, including persistent inhaler misuse despite proper training, led to the ...

COPD comprises several conditions, including chronic bronchitis and emphysema, and can be caused by irritants like smoke or ...

Background With rising concern on the global warming potential of propellants in pressurized metered dose inhalers (pMDIs) it has become increasingly important to identify patients who are able to ...

In patients with chronic obstructive pulmonary disease (COPD), the first year of using single-inhaler triple therapy is associated with slightly more major adverse cardiovascular events (MACE) than ...